Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 2Obesity 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Orlistat × Clear all
NCT01003483 2021-04-01

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Yazd Research & Clinical Center for Infertility

Phase 2 Completed
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT00704912 2016-11-07

OWL-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
217 enrolled 16 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡